Positive MRI findings in the 6 month 008 trial should prove some DMOAD capability and be understood by the layman. If you pain is diminished significantly and you have MRI evidence of less pathology its disease modifying IMHO.
- Forums
- ASX - By Stock
- PAR
- Ann: NWR Virtual Healthcare Conference Presentation
Ann: NWR Virtual Healthcare Conference Presentation, page-9
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.9M |
Open | High | Low | Value | Volume |
30.0¢ | 30.0¢ | 30.0¢ | $10 | 33 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9 | 29.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 239 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 33 | 0.300 |
5 | 176404 | 0.290 |
3 | 38593 | 0.285 |
4 | 114000 | 0.280 |
2 | 39159 | 0.275 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 50010 | 2 |
0.320 | 35000 | 1 |
0.325 | 50366 | 4 |
0.330 | 125773 | 4 |
0.335 | 10000 | 1 |
Last trade - 10.33am 16/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online